Login / Signup

Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study.

Yuzaburo InoueKanako MitsunagaTakeshi YamamotoKoki ChibaFumiya YamaideTaiji NakanoYoshinori MoritaAkiko YamaideShuichi SuzukiTakayasu ArimaKen-Ichi YamaguchiMinako TomiitaNaoki ShimojoYoichi Kohno
Published in: Pediatric rheumatology online journal (2018)
The early use of alendronate may have a preventive effect against the development of bone loss in glucocorticoid-treated patients with childhood-onset rheumatic disease.
Keyphrases
  • bone loss
  • rheumatoid arthritis
  • early life
  • high glucose
  • physical activity
  • diabetic rats
  • risk factors
  • childhood cancer
  • young adults
  • drug induced
  • newly diagnosed